key: cord-0879383-zzcsrk27
authors: Mermelstein, R. J.; Aiyer, M.; Canfield, C.; Chestek, D.; Cook, J. A.; Del Rios, M.; Diviak, K. R.; Ellison, A. M.; Gordon, H. S.; Illendula, S. D.; Kandula, M.; Klein, J. D.; Larimer, K.; Lash, J.; Lin, J.; Loeb, J. A.; Lynch, T. J.; Musick, H.; Novak, R. M.; Prendergast, H. M.; Krishnan, J. A.
title: Rapid implementation of cross-sectional study: Post-acute sequelae of SARS-CoV-2 (PASC) in a racially and ethnically diverse sample in Illinois
date: 2021-05-02
journal: nan
DOI: 10.1101/2021.04.29.21256304
sha: 5f15d2bbe1d15bcf7ce2e56ce04a66324e07d6d8
doc_id: 879383
cord_uid: zzcsrk27

ABSTRACT Little is known about the pattern and course of recovery following acute COVID-19. Increasing numbers of reports describe persistent illness following infection with SARS-COV-2, also known as Post-Acute Sequelae of SARS-CoV-2 (PASC). This report describes the methods and results of a multi-pronged strategy to rapidly identify and enroll, over a one week period in April 2021, a racially and ethnically diverse sample of individuals and to characterize PASC among a this diverse sample. Participants were recruited through community outreach, clinical registries, and research registries across four cities in Illinois to complete an online survey. We examined presence of symptoms among 246 individuals who were at least three months past testing positive for SARS-CoV-2. Respondents were 70% female; 48% Hispanic/Latinx; 18% Black, and 28% White. Most had mild illness (78% were not hospitalized), and 26% reported they had not yet returned to their usual health within 3 months of their diagnosis. The most prevalent symptoms persisting 3-months following COVID-19 diagnosis included fatigue (20%), difficulty thinking (19%), problems with taste or smell (15%), and muscle or body aches (15%). In a multivariable logistic regression model, older age (40-59 vs. 18-39 years: adjusted odds ratio [aOR] = 0.46 [95% confidence interval, 0.24 to 0.90]) and having been hospitalized with COVID-19 (vs. not hospitalized: aOR = 0.28 [0.12 to 0.64]) were independently associated with a lower likelihood of recovery within 3 months. Compromised health continued well beyond the acute phase of COVID-19 in our ethnically diverse sample, especially among older individuals and those who were hospitalized. The partnerships with community- and faith-based organizations developed for the current study offer the potential to broadly disseminate study findings and to further understand and mitigate underlying determinants of risk, severity, and duration of PASC.

presence of symptoms among 246 individuals who were at least three months past testing positive for SARS-CoV-2. Respondents were 70% female; 48% Hispanic/Latinx; 18% Black, and 28% White. Most had mild illness (78% were not hospitalized), and 26% reported they had not yet returned to their usual health within 3 months of their diagnosis. The most prevalent symptoms persisting 3-months following COVID-19 diagnosis included fatigue (20%), difficulty thinking (19%), problems with taste or smell (15%), and muscle or body aches (15%). In a multivariable logistic regression model, older age (40-59 vs. 18 organizations developed for the current study offer the potential to broadly disseminate study findings and to further understand and mitigate underlying determinants of risk, severity, and duration of PASC.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Most published reports about PASC focus on hospitalized patients with COVID-19, even though more than 90% of SARS-CoV-2 illnesses have no symptoms or result in mild symptoms and are managed as outpatients. (5) (6) (7) (8) (9) . In the U.S., Hispanic/Latinx and Black populations have a higher risk of SARS-CoV-2 infection, as well as COVID-19 associated hospitalizations and death. (10) More recent studies on PASC in the U.S. have included participants across the range of COVID-19 disease severity (11) (12) (13) (14) , but include low proportions of racial or ethnic minorities.

A better understanding of the risks and characteristics of PASC by race, ethnicity and severity of COVID-19 can help to tailor public health messaging about the consequences of COVID-19 and the importance of participating in research that will define best practices for the prevention and . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 2, 2021. ; https://doi.org/10.1101/2021.04.29.21256304 doi: medRxiv preprint management of PASC. As the COVID-19 pandemic evolves, approaches to quickly sample high-risk populations are needed for efficient and effective public health initiatives. The Illinois Network for Post-Acute Sequelae of SARS-CoV-2 (ILLInet-PASC) is a community-engaged collaboration between community-and faith-based organizations, public health departments, and health systems in metropolitan and surrounding areas of Chicago, Peoria, Rockford, and Urbana, Illinois.(15) The objectives of this report are to describe the methods and results of a multipronged strategy to rapidly (over a 1-week period) identify and enroll a diverse sample, and to characterize PASC in a predominantly Hispanic/Latinx and Black population in Illinois.

This study followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines. We employed a cross-sectional study design to collect self-reported information using an on-line questionnaire programmed with REDCap from April 7 to 12, 2021.(16) Our goal was to simultaneously employ a set of rapid recruitment approaches to maximize enrollment within a 7-day window for data collection that would yield a diverse sample of individuals living in Illinois who had tested positive for SARS-CoV-2 and who were willing to share their recovery experiences. To ensure rapid launch of the study protocol, we leveraged existing institutional review board (IRB)-approved research studies for which investigators had ongoing approval to contact participants for potential study recruitment; CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. reviewed the ILLInet-PASC study protocol and determined the study to be exempt from further review.

There were three sources of study participants.

Community outreach. We provided the IRB-approved ILLInet-PASC flyers or the URL or QR code for the on-line survey to community-based and faith-based partner organizations. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 2, 2021. ; https://doi.org/10.1101/2021.04.29.21256304 doi: medRxiv preprint

The on-line REDCap survey, in English and Spanish, was designed to take no more than 10 minutes to complete. Only adults who self-reported an age of 18 years or older were eligible to complete the survey. Once participants submitted the survey, they were invited to receive a $10 Amazon © gift card (e-code). To receive the Amazon © e-code, participants were directed to a second REDCap survey to provide their contact information, separating data from identifying information.

We assessed four domains.

Participants were asked about their age, gender, race and ethnicity.

Participants were asked to report health conditions diagnosed by their healthcare provider using a list of 18 potential comorbidities. Participants were also asked whether they currently smoked tobacco or vaped nicotine or cannabis.

3. COVID-19 testing, results, and severity. Participants were asked to indicate the month(s) they were tested for COVID-19 (from January, 2020 -April, 2021), and any month(s) they worse, or unchanged compared to before they were diagnosed with COVID-19. Participants . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 2, 2021. ; https://doi.org/10.1101/2021.04.29.21256304 doi: medRxiv preprint were also asked about whether they had recovered to their usual state of health and asked to select: No; Yes, recovered within 2 weeks; Yes, recovered within 1 month; Yes, recovered within more than 1 month, but less than 2 months; Yes, recovered within more than 2 months, but less than 3 months; Yes, recovered after 3 months. We considered responses of "No" and "recovered after 3 months" as not returning to baseline health by 3 months (PASC-3 months).

To ensure adequate follow-up time to evaluate the risk of PASC-3 months, analyses focused on individuals who reported testing positive for COVID-19 at least 3 months prior to survey completion. We used descriptive statistics of frequencies of responses, as well as chi-square analyses to examine differences in frequencies of symptoms by subgroups (e.g., by gender, race/ethnicity). Multivariable logistic regression analysis was used to determine if demographics (age, gender, race/ethnicity) and severity of COVID-19 (mild, moderate or severe) were independent predictors of incomplete return to usual health by 3 months post-COVID-19 diagnosis. A significant difference was defined as a 2-tailed p-value<0.05.

Of 401 participants who completed the on-line survey from April 7 to 12, 2021, the majority were recruited from community outreach sources (N=260, 65%), followed by COVID-19 research registries (N=75, 19%) and COVID-19 clinical registries (N=66, 16%). Most of the 401 participants were Hispanic/Latinx (47%) or Black/African-American (20%). A total of 284 (71%) participants reported a positive COVID-19 test, with a median of 4 months prior to . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 2, 2021. ; https://doi.org/10.1101/2021.04.29.21256304 doi: medRxiv preprint completing the survey (range 1 to 15 months). Of these 284, 246 (86.6%) completed the survey 3 or more months after a positive COVID-19 test ( Table 1 ).

The majority of these 246 participants (85%) had mild COVID-19, defined as not seeking medical care (53%), receiving only outpatient care (25%), or receiving care in the Emergency Department (7%). An additional 9% had moderate COVID-19, defined as being hospitalized without ICU-level care; and 5% had severe COVID-19, defined as hospitalized with ICU-level care. Most were from community-based sources (56%), women (70%) and at least 40 years old (54%). Over two-thirds were non-White (48% Hispanic/Latinx, 18% Black, 2% multiple races, 1% Asian). The five most prevalent comorbidities were obesity (38%), hypertension (27%), asthma (22%), diabetes (16%), and joint disease or osteoarthritis (11%). About 7% reported current smoking; a similar proportion (7%) reported current vaping.

Three or more months after the diagnosis of COVID-19, about 1 in 5 reported fatigue (20%), trouble concentrating (18%), or trouble thinking (18%) that was worse than before they were diagnosed with COVID-19 (Table 2) . About 1 in 4 (26%, 75/284) indicated they had not recovered fully (Table 3) . Incomplete recovery at 3 months was significantly more likely among those who were older and among those with moderate or severe COVID-19.

In a multivariable logistic regression model (Table 4) , older age and greater severity of COVID-19 were independently associated with incomplete recovery. Participants who were 40-59 years . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 2, 2021. was noted in participants who were age 60 years and older vs. age 18-39 years, though differences were not significant. Participants who were hospitalized with COVID-19 were significantly less likely to return to usual health within 3 months (vs. not hospitalized: aOR 0.28, 95% CI 0.12 to 0.64). Gender, and race and ethnicity were not significantly associated with time to recovery in the multivariable regression model, though confidence intervals were wide suggesting additional data might provide evidence for these associations.

Our combination of community-engaged enrollment, COVID-19 research registries, and COVID-19 clinical registries helped to rapidly (over 7 days) recruit a predominantly minority (Hispanic/Latinx or Black/African-American) participant population, of whom about 85% had mild (no healthcare, outpatient care, or ED care), 9% had moderate (hospitalization without ICUlevel care), and 5% had severe (hospitalization with ICU-level care) COVID-19. We found that about 1 in 4 participants did not return to their usual state of health by 3 months (PASC-3 months). Older age and more severe COVID-19 independently predicted PASC-3 months. We did not find significant gender, race or ethnic differences independently predicted the likelihood of PASC-3 months.

In the U.S., racial and ethnic minorities (e.g., Hispanic/Latinx and Black/African American populations) have a higher risk of SARS-CoV-2 infection, hospitalizations, and death.(10) Our approach to recruitment therefore used a combination of strategies, including collaborations with community partners, to rapidly recruit a diverse population including those at disproportionately . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 2, 2021. Hispanic/Latinx participants below 100. (11-13, 18, 19) The community-engaged approach to recruitment also helped us to develop the infrastructure needed for broader dissemination of study findings (e.g., through virtual townhalls, in-person vaccination drives supported by community-and faith-based organizations) and for planning and implementing other stakeholder-supported studies.

Our multi-strategy approach to recruitment helped us to enroll participants across a spectrum (mild to severe) of acute illness associated with COVID-19, with about 85% of participants reporting mild COVID-19 (not hospitalized) and about 15% reporting moderate and severe COVID-19 (hospitalized with and without ICU-level care, respectively). The current report stands in contrast to most of the published literature, which has focused on post-hospital population (5) (6) (7) 19) or ambulatory population. (11) (12) (13) 20) Our findings about the patterns of PASC symptoms (e.g., fatigue, difficulty concentrating or thinking, lost of taste or smell) and increased risk of PASC among hospititalized patients are broadly consistent with previously published reports, suggesting that our multi-pronged approach to rapid recruitment did not result in widely divergent estimates.

There is no universally agreed-upon time frame after COVID-19 diagnosis for assessing symptoms of PASC; various studies have employed a wide range of time friames after COVID-. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 2, 2021.

19 diagnosis (e.g., 2 weeks to 6 months). (7-9, 11-13, 18-21) We selected a 3-month time frame to identify better the subset of individuals who may be most at risk for ongoing health concerns.

This decision was based on concerns that a shorter time-frame (e.g., <1 month after COVID- 19) may not adequately account for trajectories of recovery from acute illness regardless of cause, while a longer time-frame (e.g., 6 months or longer after COVID-19) would ignore multiple months of physical and mental health concerns. A recently published report found an increased risk of death and greater health care utilization after hospitalizations with COVID-19 persists for at least 6-months compared to hospitalizations with influenza. (11) Taken together with the pattern of some persistent symptoms (especially anosmia and dysgeusia > 3 months), these findings suggest that PASC is not simply another name for post-hospital syndrome. (22) There were several strengths in our study design. The broad representation from communitybased partners helped us to enroll within 7 days a diverse sample of patients with a history of COVID-19 that allows for a more time-sensitive, current snap-shot of the symptom and recovery experience of individuals with COVID-19. Given the dynamics of the changing landscape of the COVID-19 pandemic, vaccination rates, and emergence of new variants,(23-26) the ILLInet-PASC consortium appears is well-positioned to conduct rapid assessments of health, symptoms, and behavioral risk patterns that can be used to inform public health strategies and research priorities to mitigate the burden from COVID-19. Our partnerships with community-and faithbased organizations offer the potential to build on this work to recruit a larger sample of individuals to systematically examine race, ethnicity, comorbid illness, vaccination, and other potential determinants of recovery; such information can help to inform policymakers about the need for socioeconomic and health-related supports during the recovery phase after SARS-CoV-. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 2, 2021. ; https://doi.org/10.1101/2021.04.29.21256304 doi: medRxiv preprint 2 infection. We are also well-positioned to test the multi-pronged strategy of community-based enrollment, and clinical and research registries to enroll participants in high-dimensional prospective cohort studies that includes the collection of patient-reported information, biospecimens (e.g., blood, stool, saliva), physical and neurocognitive data using remote participant monitoring, and imaging data (e.g., brain, lungs, heart) to identify biologic targets for treatment and prevention studies.

Our study also has limitations. We relied on self-reported data, rather than laboratory-confirmed test results for SARS-CoV-2. Our study did not employ a population-based sampling strategy, so the prevalence and duration of different symptoms may not offer generalizable estimates across the state of Illinois. Moreover, our data were collected over a one week period in April 2021 and results may change with secular trends in the number of mild, moderate, and severe cases of COVID-19 cases. Also, the size of our one-week participant sample was insufficient to adequately examine gender, race and ethnicity as predictors of PASC at 3 months. A longer duration of survey collection or additional sources of participant populations will be needed to overcome limitations due to inadequate statistical power for some analyses.

In summary, we have demonstrated that the combination of community-engaged enrollment, COVID-19 research registries, and COVID-19 clinical registries can be used to rapidly recruit a predominantly minority participant population across the spectrum of COVID-19 severity. About 1 in 4 individuals had not recovered to their usual state of health after 3 months (even fewer among older individuals and those who had been hospitalized with COVID-19). Until there are proven-effective interventions to treat PASC, public health messaging should include the importance of preventing PASC through vaccination and other strategies to prevent infection . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 2, 2021. ; https://doi.org/10.1101/2021.04.29.21256304 doi: medRxiv preprint with SARS-CoV-2. The partnerships with community-and faith-based organizations that were developed for the current study offer the potential to build on this work.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 2, 2021. ; https://doi.org/10.1101/2021.04.29.21256304 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 2, 2021. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 2, 2021. OR= Odds ratio 95% CI = 95% confidence interval . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 2, 2021. ; https://doi.org/10.1101/2021.04.29.21256304 doi: medRxiv preprint

Authors have included a competing interest statement using the ICMJE disclosure form.

The work presented was funded in part by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant UL1TR002003. The work was also supported in part with resources and the use of facilities at the Jesse Brown VA Medical Center, Chicago, Illinois. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the Department of Veterans Affairs. None of the authors or institutions at any time received payment or services from a third party for any aspect of the submitted work

All data referred to in the manuscript are available through the corresponding author.

The Institutional Review Boards at the University of Illinois Chicago (Protocol # 2021-0410) and Peoria (Protocol #1745454-1), Carle Hospital in Urbana (Protocol #21CRU3374), and Jesse Brown VA Medical Center (Protocol #162103-1) reviewed the ILLInet-PASC study protocol and determined the study to be exempt from on-going review because the data were de-identified at the time of collection.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 2, 2021. ; https://doi.org/10.1101/2021.04.29.21256304 doi: medRxiv preprint

Decline in COVID-19 Hospitalization Growth Rates Associated with Statewide Mask Mandates -10 States

US Centers for Disease Control and Prevention

Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19

Persistent Symptoms in Patients After Acute COVID-19

Post-discharge persistent symptoms and healthrelated quality of life after hospitalization for COVID-19

Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation

6-month consequences of COVID-19 in patients discharged from hospital: a cohort study

Risk for COVID-19 infection, hospitalization, and death by race/ethnicity

The clinical course of COVID-19 in the outpatient setting: A prospective cohort study. Open Forum Infectious Diseases

Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network -United States

Rapid implementation of a cohort for the study of post-acute sequelae of SARS-CoV-2 infection/COVID-19. medRxiv

WHO Working Group on the Clinical Characterisation and Management of COVID-19 infection. A minimal common outcome measure set for COVID-19 clinical research

Population-based estimates of post-acute sequelae of SARS-CoV-2 infection (PASC) prevalence and characteristics: A cross-sectional study

COVID-19 Symptoms: Longitudinal Evolution and Persistence in Outpatient Settings

Attributes and predictors of long COVID

Post-hospital syndrome--an acquired, transient condition of generalized risk

Centers for Disease Control and Prevention. COVID Data Tracker. United States Trends in Emergency Department (ED) Visits